Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 0.4% ($ weighted) with an average mark-down of 1.8% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In July, 25% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 46% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: May 31st, 2025 Reporting Period

0.4%

Appreciation/Depreciation of All Reported Holdings1

-1.8%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Einride
253.7%
Applied Intuition
115.6%
Caris
75.7%
xAI
68.9%
LifeMine
59.5%
Kardium
53.7%
Gusto
37.2%
Alif Semi
36.5%
Socure
32.5%
Meesho
26.1%
JUUL
20.8%
Lenskart
16.0%
Nuro
15.2%
Anthropic
13.3%
Crusoe Energy
10.3%
Liquid Death
9.8%
Bolt
9.5%
Databricks
8.9%
CelLink
7.5%
goPuff
7.0%
Anduril
5.9%
Figma
5.0%
Checkr
4.9%
Tarana
4.9%
AgomAb Therapeutics
4.5%
Fabletics
4.3%
Epic Games
4.1%
Moloco
2.4%
PsiQuantum
1.8%
Revolut
1.7%
Tanium
1.7%
Starling Bank
1.6%
Celestial AI
1.5%
Akeana
1.2%
Skyryse
1.2%
Stripe
0.7%
Ant Group
0.5%
Runway AI
0.4%
Element Labs
0.3%
Kartos Therapeutics
0.3%
A24 Films
0.0%
Arctic Wolf
0.0%
Atom Tickets
0.0%
Cross River
0.0%
Dragonfly Therapeutics
0.0%
GOAT
0.0%
HaulHub
0.0%
KoBold Metals
0.0%
PrognomIQ
0.0%
RefleXion Medical
0.0%
SpaceX
0.0%
T-Knife
0.0%
VideoAmp
0.0%
Medical Micro
-0.3%
Diamond Foundry
-0.4%
Epirus
-0.4%
Clio
-0.5%
DNA Script
-1.0%
ABL Space
-1.3%
Color Genomics
-1.4%
Fanatics
-1.4%
Cleerly
-1.6%
Discord
-1.6%
Thriveworks
-1.6%
Unqork
-1.7%
Klarna
-1.9%
Sila Nano
-2.7%
VAST Data
-2.8%
MasterClass
-3.0%
Zipline
-3.0%
SiMa ai
-3.2%
Waymo
-3.3%
Lime
-3.4%
Tenstorrent
-3.5%
Canva
-3.9%
Druva
-4.3%
Conformal Medical
-4.5%
Lightmatter
-4.5%
Pine Labs
-4.7%
Saluda Medical
-5.4%
Oura Health
-6.2%
Grammarly
-6.9%
Astranis
-7.5%
Cellanome
-7.8%
Locus Robotics
-8.0%
BETA Technologies
-8.1%
Blink Health
-8.2%
Verily
-8.3%
Caidya (dMed)
-8.8%
Bright Peak
-8.9%
Quell
-8.9%
Aledade
-9.1%
Insitro
-9.1%
Goop
-9.3%
Rappi
-9.3%
Deep Genomics
-9.4%
FogPharma
-9.6%
Mirador Therapeutics
-9.6%
Castle Creek
-9.9%
Candid
-10.0%
Generate Bio
-10.0%
Laronde
-10.0%
Rapyd
-10.1%
Chime
-10.4%
Redwood Materials
-10.4%
Circle
-10.5%
Asimov
-10.9%
Signifyd
-11.2%
Evozyne
-11.3%
Insightec
-11.5%
Genesis Therapeutics
-11.6%
Algolia
-11.8%
Element Bio
-12.4%
GupShup
-12.5%
Skyhawk
-13.0%
Ankyra
-13.6%
Dataminr
-14.3%
Faraday Pharma
-14.5%
Roofstock
-14.8%
Altos Labs
-15.0%
Adimab
-15.1%
Sonoma Bio
-15.2%
Tory Burch
-16.0%
SambaNova
-16.1%
Tipalti
-16.1%
City Therapeutics
-16.2%
Honor Tech
-16.2%
Bombas
-16.7%
Cardurion
-17.3%
Triveni Bio
-18.3%
Bytedance
-18.5%
Snyk
-18.5%
YuLife
-19.7%
DataRobot
-20.8%
Freenome
-21.5%
Treeline Bio
-21.9%
Asapp
-23.3%
ElevateBio
-23.9%
EndeavorBio
-25.0%
Menlo Micro
-25.9%
Resilience
-25.9%
Jumo
-30.7%
FLEXE
-31.4%
SecurityScorecard
-34.5%
Galvanize
-34.7%
Xsight Labs
-34.9%
Rad Power
-42.9%
Enevate
-44.6%
Farmers Business Network
-45.3%
Magic Leap
-47.9%
Wugen
-64.7%
Odyssey Therapeutics
-75.3%
SalioGen
-100.0%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 0.4% ($ weighted) with an average mark-down of 1.8% (equal weighted). The period saw less than one advancing company for every two declining companies.

Einride experienced the most significant mark-up, followed by Applied Intuition, Caris and xAI. FoodTech, AI & Machine Learning and E-Commerce and saw the largest mark-ups across sectors.

SalioGen experienced the most significant mark-down, followed by Odyssey Therapeutics, Wugen and Magic Leap. Among sectors, Semiconductors, HealthTech and BioTech saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
GOAT2+276.30%
Lime1+139.60%
GupShup2+130.20%
Crusoe Energy2+84.60%
Redwood Materials2+71.40%
DataRobot1+60.10%
Sila Nano1+56.90%
Anduril8+52.80%
Signifyd1+49.10%
Aledade1+48.50%
Blink Health1+46.90%
Anthropic7+40.90%
Freenome1+38.90%
VAST Data1+32.40%
Databricks8+18.00%
SpaceX7+16.60%
xAI8+13.20%
Dataminr1+12.80%
Stripe7+11.80%
Waymo2+11.10%
Klarna1+8.50%
Cross River1+5.90%
Meesho1+5.50%
Canva3+3.30%
Tenstorrent1+2.60%
Epirus2-0.20%
Discord6-0.70%
Locus Robotics1-1.10%
Revolut6-1.40%
KoBold Metals2-2.30%
Lightmatter1-2.90%
goPuff2-3.50%
Oura Health1-9.60%
Gusto1-10.10%
Bytedance7-11.20%
Grammarly2-13.30%
Bolt2-17.40%
JUUL1-18.00%
Arctic Wolf5-20.70%
Zipline2-23.30%
Rapyd1-23.30%
Algolia1-25.10%
SambaNova2-25.60%
Asapp1-25.90%
Liquid Death1-26.20%
Fanatics2-33.80%
Snyk1-35.00%
VideoAmp1-36.60%
Epic Games5-40.40%
PsiQuantum2-41.50%
Checkr1-50.90%
Celestial AI1-55.00%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In July, 25% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 46% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, GOAT, Lime, GupShup and Crusoe Energy had the highest positive variance in reported marks versus ZX Index Values. Celestial AI, Check, PsiQuantum and Epic Games had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Xsight Labs.67$4.75$8.00$1.68
Rad Power.57$0.22$0.37$0.09
Caris.45$6.18$9.06$1.80
Nuro.41$7.48$12.98$5.52
DNA Script.39$197.07$231.97$30.62

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, Xsight Labs ($1.68 - $8.00) saw the highest share price variance across funds followed by Rad Power ($0.09 - $0.37) and Caris ($1.80 - $9.06).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Thriveworks
14
Einride, JUUL
8
Cellink
7
Socure
4
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Canva, Clio
6
Honor Tech
6
Lightmatter
6
SecurityScorecard
6

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Thriveworks saw its first positive reversal in fourteen quarters while JUUL saw its first positive reversal in eight quarters. Canva, Clio, Honor Tech, Lightmatter and SecurityScorecard all saw their first negative reversals in six quarters.

Disclaimer

This report is based on data reported by 300+ funds and $65+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report July not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right